Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Feb;25(2):245-248.
doi: 10.3201/eid2502.180836.

Lassa Fever in Travelers from West Africa, 1969-2016

Meta-Analysis

Lassa Fever in Travelers from West Africa, 1969-2016

Aaron Kofman et al. Emerg Infect Dis. 2019 Feb.

Abstract

Lassa virus is a rodentborne arenavirus responsible for human cases of Lassa fever, a viral hemorrhagic fever, in West Africa and in travelers arriving to non-Lassa-endemic countries from West Africa. We describe a retrospective review performed through literature search of clinical and epidemiologic characteristics of all imported Lassa fever cases worldwide during 1969-2016. Our findings demonstrate that approximately half of imported cases had distinctive clinical features (defined as fever and >1 of the following: pharyngitis, sore throat, tonsillitis, conjunctivitis, oropharyngeal ulcers, or proteinuria). Delays in clinical suspicion of this diagnosis were common. In addition, no secondary transmission of Lassa fever to contacts of patients with low-risk exposures occurred, and infection of high-risk contacts was rare. Future public health investigations of such cases should focus on timely recognition of distinctive clinical features, earlier treatment of patients, and targeted public health responses focused on high-risk contacts.

Keywords: Lassa fever; West Africa; travel medicine; viruses; zoonoses; zoonotic diseases.

PubMed Disclaimer

References

    1. Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg. 1970;19:670–6. 10.4269/ajtmh.1970.19.670 - DOI - PubMed
    1. World Health Organization. Lassa fever fact sheet [cited 2018 May 15]. http://www.who.int/mediacentre/factsheets/fs179
    1. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20–6. 10.1056/NEJM198601023140104 - DOI - PubMed
    1. Riner A, Chan-Tack KM, Murray JS. Original research: Intravenous ribavirin—review of the FDA’s Emergency Investigational New Drug Database (1997-2008) and literature review. Postgrad Med. 2009;121:139–46. 10.3810/pgm.2009.05.2014 - DOI - PubMed
    1. Fisher-Hoch SP, Price ME, Craven RB, Price FM, Forthall DN, Sasso DR, et al. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet. 1985;2:1227–9. 10.1016/S0140-6736(85)90752-4 - DOI - PubMed